These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11008484)

  • 1. Cyclic nucleotide phosphodiesterases: relating structure and function.
    Francis SH; Turko IV; Corbin JD
    Prog Nucleic Acid Res Mol Biol; 2001; 65():1-52. PubMed ID: 11008484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
    Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
    Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
    Francis SH; Blount MA; Corbin JD
    Physiol Rev; 2011 Apr; 91(2):651-90. PubMed ID: 21527734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
    Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
    Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
    Huai Q; Wang H; Zhang W; Colman RW; Robinson H; Ke H
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9624-9. PubMed ID: 15210993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase.
    Huang D; Hinds TR; Martinez SE; Doneanu C; Beavo JA
    J Biol Chem; 2004 Nov; 279(46):48143-51. PubMed ID: 15331594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
    Manganiello VC; Murata T; Taira M; Belfrage P; Degerman E
    Arch Biochem Biophys; 1995 Sep; 322(1):1-13. PubMed ID: 7574662
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterases in cultured normal and RCS rat pigment epithelium: kinetics of cyclic AMP and cyclic GMP hydrolysis.
    Kurtz MJ; Edwards RB; Schmidt SY
    Exp Eye Res; 1987 Jul; 45(1):67-75. PubMed ID: 2820772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants.
    Wang P; Wu P; Egan RW; Billah MM
    Gene; 2003 Sep; 314():15-27. PubMed ID: 14527714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP and regulation of cyclic nucleotide hydrolysis.
    Sonnenburg WK; Beavo JA
    Adv Pharmacol; 1994; 26():87-114. PubMed ID: 8038108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
    Day JP; Dow JA; Houslay MD; Davies SA
    Biochem J; 2005 May; 388(Pt 1):333-42. PubMed ID: 15673286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
    Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
    Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
    Maurice DH
    Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.